Clinical Trials Browser

Interventional × enadenotucirev × Genitourinary × Clear all

NCT02028442 2020-03-12

EVOLVE

Phase 1/2 Completed

GastrointestinalGenitourinary

Urinary Bladder Neoplasms, Colorectal Neoplasms